Add like
Add dislike
Add to saved papers

MitoTarget Modeling Using ANN-QSTR Approach Based on Fractal SEM Nano-Descriptors: Carbon Nanotubes as Mitochondrial F0F1-ATPase Inhibitors.

Recently, it has been suggested that the mitochondrial oligomycin A-sensitive F0-ATPase subunit is an uncoupling channel linked to apoptotic cell death and as such, the toxicological inhibition of mitochondrial F0-ATP hydrolase can be an interesting mitotoxicity-based therapy under pathological conditions. In addition, carbon nanotubes (CNTs) have shown to offer higher selectivity like mitotoxic-targeting nanoparticles. In this work, linear and non-linear nano-quantitative structure-toxicity relationship-based artificial neural network (ANN-QSTR) models were setup using the fractal dimensions calculated from CNTs as source of structural complex-geometrical information to predict the potential ability of CNT-family members to induce mitochondrial toxicity-based inhibition of the mitochondrial H+-F0F1-ATPase from in vitro assays. The attained experimental data suggest that CNTs have high ability to inhibit the F0-ATPase active-binding site following the order: oxidizedCNT (CNTCOOH > CNTOH) > pristineCNT and mimicking the oligomycin A mitotoxicity behavior. Meanwhile the performance of the ANN-QSTR models was found to be improved by including different non-linear combinations of the calculated fractal Scanning Electron Microscopy (SEM) nano-descriptors, leading to models with excellent internal accuracy and predictivity on external data. Finally, the present study can contribute towards the rational-design of carbon nanomaterials and opens new opportunities towards mitochondrial nanotoxicology-based in silico models.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app